Dingcong, Reymund C.

HRN: 22-45-39  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/04/2023
NYSTATIN 100,000IU/ML, 30ML SUSPENSION (BOT)
01/04/2023
01/11/2023
PO
400,000iu
Q6
Oral Candidiasis
Waiting Final Action 
01/05/2023
CEFTRIAXONE 1G (VIAL)
01/05/2023
01/11/2023
IVT
2gms
Od
T/c Immunocompromised State Sec To Bacterial Meningitis
Waiting Final Action 
01/06/2023
BENZYL PENICILLIN 1MU (VIAL)
01/06/2023
01/20/2023
IM
2.4 Units
Once A Week X 3weeks
Syphilis
Waiting Final Action 
01/06/2023
COTRIMOXAZOLE 960MG (TAB)
01/06/2023
01/21/2023
PO
2 Tabs
Tid
Pneumocystis Jiroveci Infection, Immunocompromised State, Hiv Infection
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: